Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops

PharmacoEconomics

Volumn 23, Issue 9, 2005, Pages 913-926

  Desjeux, Guillaume ^a   Galoisy Guibal, Laurent ^a   Colin, Cyrille ^b  

^a HIA Desgenettes   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FMSE INMMUN; MENINGITIS VACCINE; TICK BORNE ENCEPHALITIS VACCINE; TICOVAC;

ARMY; CALCULATION; CAUSE OF DEATH; COST BENEFIT ANALYSIS; DRUG EFFECT; DRUG EFFICACY; FRANCE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LITERATURE; MENINGITIS; METHODOLOGY; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REHABILITATION CENTER; REVIEW; SENSITIVITY ANALYSIS; SEROCONVERSION; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VACCINATION REACTION;

COST-BENEFIT ANALYSIS; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; HUMANS; MILITARY PERSONNEL; VACCINATION; VIRAL VACCINES;

EID: 24944569271     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200523090-00004     Document Type: Review

References (52)

1. Kunz C. Tick-borne encephalitis in Europe. Acta Leiden 1992; 60 (2): 1-14
2. Kaiser R. Tick borne encephalitis (TBE) in Germany and clinical course of disease. Int J Med Microbiol 2002; 291 Suppl. 33: 58-61
3. Günther G, Haglund M, Lindquist L, et al. Tick borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 1997; 244: 230-48
4. Zeman P. Objective assessment of risk maps of tick-borne encephalitis and Lyme borreliosis based ion spatial patterns of located cases. Int J Epidemiol 1997; 5: 1121-9
5. Kantoch M. Tick-borne encephalitis in Poland. Sonderdrück aus ellipse 1991; 29: 461
6. World Health Organization. Tick borne encephalitis. Wkly Epidemiol Rec 1995; 17: 120-2
7. Kahl O. Fatal attraction or how do we get tick bites? Infection 1996; 24: 394-5
8. Klockmann U, Bock H, Kwasny H, et al. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization. Vaccine 1991; 9: 42-6
9. Direction de la Fonction Militaire et du Personnel Civil. Quel dispositif pour le personnel Militaire? BuS Bulletin d'information Sociale de la Défense 1999; 40: 26-33
10. Ackermann R, Krüger K, Roggendorf M, et al. Die verbreitung der frühsommer-meningoenzephalitis in der Bundesrepublik Deutschland. Dtsch Med Wochenschr 1986; 111: 927-33
11. Craig S, Cuthie J, Welch G, et al. Tick borne encephalitis vaccine and natural infection with central European encephalitis (CEE) virus, US military experience in operation joint endeavor, Bosnia-Herzegovina. Medical Surveillance Monthly Report 1998; 4: 11-2
12. McNeil J, Lednar W, Stansfield S, et al. Central European tick-borne encephalitis: assessment of risk for persons in the armed services and vacationers. J Infect Dis 1985; 152: 650-1
13. Clement J, Leirs H, Armour V, et al. Serologic evidence for tick borne encephalitis (TBE) in North-American military stationed in Germany. Acta Leiden 1992; 60: 15-7
14. Haglund M, Forsgren M, Lindh G, et al. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 1996; 28 (3): 217-24
15. Kaiser R. The clinical and epidemiological profile of tick borne encephalitis in Southern Germany 1994-1998. Brain 1999; 122: 2067-78
16. Harabacz I, Bock H, Jüngst CH, et al. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 1992; 10: 145-50
17. Bock H, Klockmann U, Jüngst C, et al. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine 1990; 8: 23-4
18. Hedenström M, Heberle U, Theobald K. Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immuno-globulin on seroconversion and rate of adverse events. Vaccine 1995; 13: 759-62
19. Grzeszczuk A, Sokolewicz-Bobrowska E, Prokopowicz D. Adverse reactions to tick-borne encephalitis vaccine: FMSE-Immun Infection 1998; 28: 385-8
20. Hofmann H. Muß nach FMSE-Impfung mit dem Auftreten neurologischer Störungen gerechnet werden? Wien Klin Wochenschr 1995; 107 (17): 509-15
21. Bohus M, Glocker FX, Jost S, et al. Myelitis after immunization against tick borne encephalitis. Lancet 1993; 324: 239-40
22. Jellinger K. Frühsommer-meningoenzephalitis-impfung. Dtsch Med Wochenschr 1992; 117: 1928-9
23. Moorthi S, Schneider WN, Dombovy ML. Rehabilitation outcomes in encephalitis: a retrospective study 1990-1997. Brain Inj 1999; 13: 139-46
24. Decam C. Surveillance des effets adverses post vaccinaux. Institut de Médecine Tropicale du Service de Santé des Armées, Marseille, 2003
25. Clinical expert report, supervision of Istvan (MD), Hungary document from Baxter-immuno®
26. Girgsdies OE, Rosenkranz G. Tick-borne encephalitis: development of a pediatric vaccine: a controlled, randomized, double-blind and multicentre study. Vaccine 1996; 14: 1421-8
27. Klockmann U, Krivanec K, Stephenson JR, et al. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Vaccine 1991; 9: 210-2
28. Ministère de la Défense. Tarifs des prestations du service de santé des armées pour l'année 2003. Bulletin Officiel Chronologique-Partie Principale 2003, no. 37 du 08 Septembre 2003
29. Honore F. Technical report, Evasan. Direction Centrale du Service de Santé des Armées. Paris, 2003
30. Baxter-Immuno, 2002
31. Carabin H, Edmunds WJ, Kou U, et al. The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health 2002; 2: 22
32. Meynard J, Bel J, Letourneur F, et al. Première vaccination collective par le Menomune® des militaires français en OPEX. Med Armees 2004; 32: 143-7
33. Ministère de la Défense. Secrétariat Général pour l'Administration. Sous Direction des Etudes et Synthèses-Mémento des coûts moyens annuels du personnel militaire. Année 2003
34. Décret no. 2003-328 du 9 Avril 2003, Journal officiel de la République Française, 12 Avril 2003; 87, 6526
35. Service de Pension des Armées. Guide-Barème des invalidités applicable au titre du code des pensions militaires d'invalidité et des victimes de la guerre. Secrétariat d'état aux anciens combattants. Paris: Imprimerie Nationale, 1976
36. Direction de la Fonction Militaire et des Personnels Civils. Observatoire Social de la Défense. Bilan Social 2003. Paris, 2004
37. Pison G. La population en France en 2002. Popul Soc (Paris) 2003; 388: 1-4
38. Nichol K. Cost benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161: 749-59
39. Eltari E. Epidemiology of tick borne encephalitis in Albania. Ellipse 1991; 29: 1-2
40. Borcic B. The nosoarea of tick borne encephalitis in Croatia. Ellipse 1991; 29: 2-3
41. Antoniadis A, Alexiou-Daniel ST, Polyzoni T. Tick borne encephalitis in Greece. Ellipse 1991; 29: 10
42. Ferenczi E, Molnar E. Tick borne encephalitis in Hungary in the last ten years. Ellipse 1991; 29: 10-1
43. Kraigher A, Avsic-Zupanc T, Kovacevic M, et al. Tick borne encephalitis in Slovenia. Ellipse 1991; 29: 14-5
44. Rubio F, Couvert M, Champier G, et al. Des Balkans vers Villacoublay. Rétrospective des évacuations sanitaires aériennes. Med Armees 2001; 29: 573-80
45. Durand JP. Enquête sérologique chez les personnes ayant séjourné au Kosovo pendant l'été 2001. Institut de Médecine Tropicale. Unité de Virologie: 10
46. Koopmanschap M, Rutten F. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4: 446-54
47. Favreau-L'hotellier M. Le marché interne du travail et le capital humain: l'exemple de l'institution militaire. Journées scientifiques de l'université d'Angers: Le Capital humain. Dimensions économiques et managériales. Angers, le 22 Octobre 1998
48. Lucas RE. Making a miracle. Econometrica 1993; 61: 251-72
49. Koopmanschap M, Rutten F, van Ineveld B, et al. The friction cost method for measuring indirect cost of disease. J Health Econ 1995; 14: 171-89
50. Jefferson TO, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in Health Care. JAMA 2002; 287: 2809-18
51. Jefferson TO, Berhens RH, Demicheli V. Should British soldiers be vaccinated against hepatitis A? An economic analysis. Vaccine 1994; 12: 1379-83
52. Desjeux G, Lemardeley P, Colin C, et al. Etude coût bénéfice de la vaccination contre l'encéphalite à tique chez les militaires français au Kosovo. Rev Epidemiol Sante Publique 2001; 49: 249-57